Sorafenib, doesn't it have any competitor in advanced hepatocellular carcinoma?

Research output: Contribution to journalEditorial

Original languageEnglish
Pages (from-to)1585-1586
Number of pages2
JournalJournal of Gastroenterology and Hepatology (Australia)
Volume26
Issue number11
DOIs
Publication statusPublished - 2011 Jan 1

Fingerprint

Hepatocellular Carcinoma
sorafenib

All Science Journal Classification (ASJC) codes

  • Gastroenterology
  • Hepatology

Cite this

@article{74981a624e734138a92b2ae5008f2e15,
title = "Sorafenib, doesn't it have any competitor in advanced hepatocellular carcinoma?",
author = "doyoung kim and KwangHyub Han",
year = "2011",
month = "1",
day = "1",
doi = "10.1111/j.1440-1746.2011.06901.x",
language = "English",
volume = "26",
pages = "1585--1586",
journal = "Journal of Gastroenterology and Hepatology (Australia)",
issn = "0815-9319",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - Sorafenib, doesn't it have any competitor in advanced hepatocellular carcinoma?

AU - kim, doyoung

AU - Han, KwangHyub

PY - 2011/1/1

Y1 - 2011/1/1

UR - http://www.scopus.com/inward/record.url?scp=80054953042&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054953042&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1746.2011.06901.x

DO - 10.1111/j.1440-1746.2011.06901.x

M3 - Editorial

VL - 26

SP - 1585

EP - 1586

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

SN - 0815-9319

IS - 11

ER -